RxDoctor Payments Data

Margot Vloka, MD

Clinical Cardiac Electrophysiology · Aurora, CONPI 1174517775

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (55.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by B. Braun Melsungen AG at 55.8% of the total. Reporting peaked in 2019 at $21,560 and has fallen 83.9% since, to $3,464 in 2025.

$103,609in general payments, 2019–2025

Across 533 payments — averaging $194.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • B. Braun Melsungen AG$58K
  • Atricure, Inc.$27K
  • Medtronic$6K
  • Acutus Medical, Inc.$4K
  • Boston Scientific$3K
  • Stereotaxis Inc$2K
  • plus $3K from 11 others
$189,317in research payments, 2019–2025

Across 250 payments — averaging $757.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$102K
  • Biotronik Inc.$34K
  • Cvrx, Inc.$31K
  • Medtronic$22K

What the payments were for

  • Royalty or licence$57,81656%
  • Consulting fees$9,6759%
  • Speaking & faculty fees$80%
  • Travel & lodging$23,73423%
  • Food & beverage$12,34712%
  • Education$290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,609 in reported general payments places this provider in the 85th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$130,466
Medicare patients
800
Services billed
2,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$150,017
Metoprolol Succinate485$11,118
Nebivolol Hcl32$2,437
Diltiazem 24hr Er (Cd)Diltiazem Hcl35$2,121
Carvedilol61$964
Bisoprolol Fumarate14$429
Metoprolol Tartrate30$147
Hydralazine Hcl16$104

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →